Pharmaceutical Companies

Pieris Pharmaceuticals

Country: 🇺🇸United States

Ownership: Public

Established: 2001-01-01

Employees: 50

Market Cap: $23.4M

Website: http://www.pieris.com

Pieris Pharmaceuticals

🇺🇸United States

Ownership: Public

Established: 2001-01-01

Employees: 50

Market Cap: $23.4M

Website: http://www.pieris.com

Matinas Biopharma, Inc.

Country: 🇺🇸United States

Ownership: Subsidiary

Established: -

Employees: -

Market Cap: $23.4M

Website: -

Matinas Biopharma, Inc.

🇺🇸United States

Ownership: Subsidiary

Established: -

Employees: -

Market Cap: $23.4M

Website: -

TherapeuticsMD

Country: 🇺🇸United States

Ownership: Public

Established: 2008-01-01

Employees: 1

Market Cap: $22.1M

Website: http://www.therapeuticsmd.com

TherapeuticsMD, Inc. operates as a pharmaceutical company. It focuses on the development and commercialization of products for women. The firm's technology, SYMBODA, develops advanced hormone therapy pharmaceutical products to enable delivery of bio-identical hormones through a variety of dosage forms and administration routes. It also manufactures and distributes branded and generic prescription prenatal vitamins, a...

TherapeuticsMD

🇺🇸United States

Ownership: Public

Established: 2008-01-01

Employees: 1

Market Cap: $22.1M

Website: http://www.therapeuticsmd.com

bioAffinity Technologies

Country: 🇺🇸United States

Ownership: -

Established: -

Employees: 75

Market Cap: $21.7M

Website: -

bioAffinity Technologies, Inc. operates as a development-stage company addressing the significant unmet need for non-invasive, early-stage cancer diagnosis and treatment. The firm develops proprietary in-vitro diagnostic tests and targeted cancer therapeutics using breakthrough technology that preferentially targets cancer cells. The company was founded on March 26, 2014 and is headquartered in San Antonio, TX.

bioAffinity Technologies

🇺🇸United States

Ownership: -

Established: -

Employees: 75

Market Cap: $21.7M

Website: -

Lyra Therapeutics

Country: 🇺🇸United States

Ownership: Public

Established: 2005-01-01

Employees: 145

Market Cap: $21.6M

Website: http://www.lyratherapeutics.com

Lyra Therapeutics

🇺🇸United States

Ownership: Public

Established: 2005-01-01

Employees: 145

Market Cap: $21.6M

Website: http://www.lyratherapeutics.com

NRX Pharmaceuticals

Country: 🇺🇸United States

Ownership: Public

Established: -

Employees: -

Market Cap: $21M

Website: http://www.nrxpharma.com

NRX Pharmaceuticals, Inc. is a clinical-stage small molecule pharmaceutical company. It engages in developing of novel therapeutics for the treatment of central nervous system disorders and life-threatening pulmonary diseases. The company was founded on September 18, 2017 and is headquartered in Wilmington, DE.

NRX Pharmaceuticals

🇺🇸United States

Ownership: Public

Established: -

Employees: -

Market Cap: $21M

Website: http://www.nrxpharma.com

Ai-Media Technologies Ltd

Country: 🇺🇸United States

Ownership: -

Established: -

Employees: 610

Market Cap: $20.9M

Website: -

AIM ImmunoTech, Inc. is a immuno-pharma company, which focuses on the research and development of therapeutics to treat multiple types of cancers, various viruses and immune-deficiency disorders. Its products include Alferon N Injection and Ampligen. The Alferon N Injection is a purified, natural source, glycosylated, multispecies alpha interferon product, composed of eight forms of high-purified alpha interferon. Th...

Ai-Media Technologies Ltd

🇺🇸United States

Ownership: -

Established: -

Employees: 610

Market Cap: $20.9M

Website: -

ImmunoPrecise Antibodies

Country: 🇨🇦Canada

Ownership: Public

Established: 1983-01-01

Employees: 101

Market Cap: $20.9M

Website: http://www.ipatherapeutics.com

ImmunoPrecise Antibodies Ltd. is a therapeutic antibody discovery company, which engages in the provision of human therapeutic antibody discovery and development services. The firm offers a selection of antibodies, enzymes, enzymes activity assays, arthritis animal products, proteins, deiminated proteins, and hybridoma licensing for research purposes. The company was founded by Robert Beecroft on November 22, 1983 an...